ATP1A3 and early-onset autosomal dominant Alzheimer disease: ATP1A3+ EVs isolated from plasma from individualswith Alzheimer's disease demonstrated amyloid-β positivity,providing superior diagnostic accuracy compared to conventional plasmabiomarkers.